## Protocol Section
### Identification Module
**NCT ID:** NCT03516279

**Brief Title:** Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

**Official Title:** Phase II Study of Adding the Anti-PD-1 Pembrolizumab to Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia and Persistently Detectable Minimal Residual Disease

#### Organization Study ID Info
**ID:** EA9171
#### Organization
**Class:** NETWORK
**Full Name:** Eastern Cooperative Oncology Group
#### Secondary ID Infos
**Domain:** CTRP (Clinical Trial Reporting Program)
**ID:** NCI-2017-02161
**Type:** REGISTRY
**Domain:** ECOG-ACRIN Cancer Research Group
**ID:** EA9171
**Type:** OTHER
**Domain:** CTEP
**ID:** EA9171
**Type:** OTHER
**ID:** U10CA180820
**Link:** https://reporter.nih.gov/quickSearch/U10CA180820
**Type:** NIH
### Status Module
#### Completion Date
**Date:** 2031-08-31

**Type:** ESTIMATED

#### Expanded Access Info
#### Last Update Post Date
**Date:** 2023-11-28

**Type:** ACTUAL

**Last Update Submit Date:** 2023-11-27

**Overall Status:** RECRUITING

#### Primary Completion Date
**Date:** 2028-08-31

**Type:** ESTIMATED

#### Start Date
**Date:** 2019-06-26

**Type:** ACTUAL

**Status Verified Date:** 2023-11

#### Study First Post Date
**Date:** 2018-05-04
**Type:** ACTUAL
**Study First Submit Date:** 2018-04-24
**Study First Submit QC Date:** 2018-04-24
### Sponsor Collaborators Module

#### Collaborators

**Class:** NIH

**Name:** National Cancer Institute (NCI)

#### Lead Sponsor

**Class:** NETWORK

**Name:** ECOG-ACRIN Cancer Research Group

#### Responsible Party

**Type:** SPONSOR

### Oversight Module

**Is FDA Regulated Device:** False

**Is FDA Regulated Drug:** True

**Is US Export:** True

**Oversight Has DMC:** True

### Description Module

**Brief Summary:** This phase II trial studies how well pembrolizumab and dasatinib, imatinib mesylate, or nilotinib work in treating patients with chronic myeloid leukemia and persistent detection of minimal residual disease, defined as the levels of a gene product called bcr-abl in the blood. Monoclonal antibodies, such as pembrolizumab, may interfere with the ability of cancer cells to grow and spread. Dasatinib, imatinib mesylate, and nilotinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Giving pembrolizumab and dasatinib, imatinib mesylate, or nilotinib may work better in treating patients with chronic myeloid leukemia.

**Detailed Description:** PRIMARY OBJECTIVES:

I. Assess the proportion of chronic myelogenous leukemia (CML) patients on stable-dose tyrosine kinase inhibitor (TKI) who convert to undetectable minimal residual disease (UMRD) (molecular response \[MR\]\^4.5) during or within 2 years of initiating pembrolizumab therapy.

SECONDARY OBJECTIVES:

I. Among patients who have converted to UMRD (MR\^4.5), assess the proportion of CML patients who maintain UMRD for 6 months and 12 months.

II. Among patients who have converted to UMRD (MR\^4.5), assess the proportion of CML patients who discontinue their TKI.

III. Among patients who have converted to UMRD (MR\^4.5), assess the proportion of CML patients who are UMRD and TKI-free at 2 years from first determined UMRD.

IV. Assess the proportion of CML patients who develop grade 3 or 4 immune related adverse events related to pembrolizumab treatment during the first 2 years after registration (not including grade 3 events that respond to corticosteroids and improve to grade 1 or less within 4 weeks).

OUTLINE:

Patients receive pembrolizumab intravenously (IV) over 30 minutes on day 1 and dasatinib, imatinib mesylate, or nilotinib orally (PO) as clinically indicated per the treating physician. Treatment repeats every 21 days for up to 18 courses in the absence of disease progression or unacceptable toxicity. Patients with detectable MRD after course 18 continue pembrolizumab and dasatinib, imatinib mesylate, or nilotinib every 21 days for up to an additional 18 courses in the absence of disease progression or unacceptable toxicity. Patients with UMRD at any time before course 18 discontinue pembrolizumab after course 18 and continue dasatinib, imatinib mesylate, or nilotinib every 21 days for up to an additional 18 courses in the absence of disease progression or unacceptable toxicity.

After completion of study treatment, patients are followed up every 6 months for 6 years from the date of registration.

### Conditions Module

**Conditions:**

- Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

- Minimal Residual Disease

### Design Module

#### Design Info

**Allocation:** NA

**Intervention Model:** SINGLE_GROUP

##### Masking Info

**Masking:** NONE

**Primary Purpose:** TREATMENT

#### Enrollment Info

**Count:** 40

**Type:** ESTIMATED

**Phases:**

- PHASE2

**Study Type:** INTERVENTIONAL

### Arms Interventions Module

#### Arm Group 1

**Description:** Patients receive pembrolizumab IV over 30 minutes on day 1 and dasatinib, imatinib mesylate, or nilotinib PO as clinically indicated per the treating physician. Treatment repeats every 21 days for up to 18 courses in the absence of disease progression or unacceptable toxicity. Patients with detectable MRD after course 18 continue pembrolizumab and dasatinib, imatinib mesylate, or nilotinib every 21 days for up to an additional 18 courses in the absence of disease progression or unacceptable toxicity. Patients with UMRD at any time before course 18 discontinue pembrolizumab after course 18 and continue dasatinib, imatinib mesylate, or nilotinib every 21 days for up to an additional 18 courses in the absence of disease progression or unacceptable toxicity.

**Intervention Names:**

- Drug: Dasatinib

- Drug: Imatinib Mesylate

- Other: Laboratory Biomarker Analysis

- Drug: Nilotinib

- Biological: Pembrolizumab

**Label:** Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Type:** EXPERIMENTAL

### Interventions

#### Intervention 1

**Arm Group Labels:**

- Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Description:** Given PO

**Name:** Dasatinib

**Other Names:**

- BMS-354825

- Sprycel

**Type:** DRUG

#### Intervention 2

**Arm Group Labels:**

- Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Description:** Given PO

**Name:** Imatinib Mesylate

**Other Names:**

- CGP 57148

- CGP57148B

- Gleevec

- Glivec

- STI 571

- STI-571

- STI571

**Type:** DRUG

#### Intervention 3

**Arm Group Labels:**

- Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Description:** Correlative studies

**Name:** Laboratory Biomarker Analysis

**Type:** OTHER

#### Intervention 4

**Arm Group Labels:**

- Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Description:** Given PO

**Name:** Nilotinib

**Other Names:**

- AMN 107

- Tasigna

**Type:** DRUG

#### Intervention 5

**Arm Group Labels:**

- Treatment (pembrolizumab, dasatinib, imatinib, nilotinib)

**Description:** Given IV

**Name:** Pembrolizumab

**Other Names:**

- Keytruda

- Lambrolizumab

- MK-3475

- SCH 900475

**Type:** BIOLOGICAL

### Outcomes Module

#### Primary Outcomes

**Description:** Will be reported with exact confidence intervals. The binomial test will be used to test the null hypothesis that this proportion is 0.2 with the alternative hypothesis being that this proportion is greater than 0.2.

**Measure:** Proportion of patients on tyrosine kinase inhibitor (TKI) who convert to undetectable minimal residual disease (UMRD)

**Time Frame:** Up to 2 years of initiating pembrolizumab

#### Secondary Outcomes

**Description:** Will be assessed among patients who achieve UMRD within two years of initiating pembrolizumab. The proportions will be reported with exact confidence intervals.

**Measure:** Proportion of patients who maintain UMRD for 6 months

**Time Frame:** Up to 6 years

**Description:** Will be assessed among patients who achieve UMRD within two years of initiating pembrolizumab. The proportions will be reported with exact confidence intervals.

**Measure:** Proportion of patients who maintain UMRD for 6 and 12 months

**Time Frame:** Up to 6 years

**Description:** Will be assessed among patients who achieve and maintain UMRD within two years of initiating pembrolizumab. The proportions will be reported with exact confidence intervals.

**Measure:** Proportion of patients who meet the criteria for discontinuing TKI

**Time Frame:** Up to 6 years

**Description:** Will be assessed among patients who have converted to UMRD (molecular response \[MR\]\^4.5) and discontinued TKI. The proportions will be reported with exact confidence intervals.

**Measure:** Proportion of patients who maintain UMRD for 2 years after first achieving UMRD

**Time Frame:** Up to 6 years

**Description:** Will be tabulated based on grade Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.

**Measure:** Proportion of patients who develop grade 3 or 4 immune related adverse events (not including grade 3 events that respond to corticosteroids and improve to grade 1 or less within 4 weeks)

**Time Frame:** Up to 6 years

### Eligibility Module

**Eligibility Criteria:** Inclusion Criteria:

* PREREGISTRATION (STEP 0): Patient has pathologically-confirmed chronic phase-CML on a first line TKI and must meet the following criteria:

  * The patient has to be on first-line TKI therapy (the same TKI) for at least 2 years prior to pre-registration
  * Has been in MMR (i.e. MR\^3) but still have detectable BCR-ABL transcript by a standard real-time quantitative polymerase chain reaction (RQ-PCR) assay with a limit of detection (sensitivity) of 4.5 for at least 12 months from the first documentation of the MMR
  * Patient has not achieved MR\^4.5 (complete molecular remission \[CMR\]) within the time of initiation of TKI therapy and pre-registration
* PREREGISTRATION (STEP 0): Patient must be scheduled to undergo a standard of care bone marrow biopsy within 7 days of step 0 registration
* PREREGISTRATION (STEP 0): Peripheral blood must be collected for submission to Fred Hutchinson Cancer Research Center for central assessment of the establishment of BCR/ABL status to confirm patient?s eligibility for registration to Step 1; Fred Hutchinson will forward results within 1-2 business days of receipt of the peripheral blood to the submitting institution
* REGISTRATION TO TREATMENT (STEP 1): Institution has received central BCR-ABL test results confirming MRD positive status
* REGISTRATION TO TREATMENT (STEP 1): Patients have an Eastern Cooperative Oncology Group (ECOG) performance status of 0-1
* REGISTRATION TO TREATMENT (STEP 1): No active hemolytic anemia requiring immunosuppressive therapy or other pharmacologic treatment; patients who have a positive Coombs test but no evidence of hemolysis are NOT excluded from participation
* REGISTRATION TO TREATMENT (STEP 1): No current use of corticosteroids; EXCEPTION: Low doses of steroids (\< 10 mg of prednisone or equivalent dose of other steroid) used for treatment of non-hematologic medical condition (e.g. chronic adrenal insufficiency) is permitted
* REGISTRATION TO TREATMENT (STEP 1): No other active primary malignancy (other than non-melanomatous skin cancer or carcinoma in situ of the cervix) requiring treatment or limiting expected survival to =\< 2 years

  * NOTE: If there is a history of prior malignancy, they must not be receiving other specific treatment (other than hormonal therapy for their cancer)
* REGISTRATION TO TREATMENT (STEP 1): Women must not be pregnant or breastfeeding; patients must also not expect to conceive or father children from the time of registration, while on study treatment, and continue for 120 days after the last dose of study treatment; all females of childbearing potential must have a negative urine or serum pregnancy within 72 hours prior to receiving the first dose of pembrolizumab; if the urine test is positive or cannot be confirmed as negative, a serum pregnancy test will be required; a female of childbearing potential is any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has not undergone a hysterectomy or bilateral oophorectomy; or 2) has not been naturally postmenopausal for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
* REGISTRATION TO TREATMENT (STEP 1): Women of childbearing potential and sexually active males must use an accepted and effective method of contraception or to abstain from sexual from time of registration, while on study treatment, and continue for 120 days after the last dose of study treatment
* REGISTRATION TO TREATMENT (STEP 1): Patients must have been on a stable dose of the TKI for the last 3 months prior to pre-registration
* REGISTRATION TO TREATMENT (STEP 1): Patient may not be currently participating and receiving study therapy or have participated in a study of an investigational agent and received study therapy or used an investigational device within 4 weeks of the first dose of treatment
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have a diagnosis of immunodeficiency or be receiving systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior to the first dose of treatment
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have a known history of active TB (Bacillus Tuberculosis)
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have a history of hypersensitivity to pembrolizumab or any of its excipients
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have received a prior anti-cancer monoclonal antibody (mAb) within 4 weeks prior to study registration or have not recovered (i.e., =\< grade 1 or at baseline) from adverse events due to agents administered more than 4 weeks earlier
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have had prior chemotherapy, targeted small molecule therapy (aside from imatinib, dasatinib, or nilotinib), or radiation therapy within 2 weeks prior to study registration; patients also must have recovered from all adverse events due to a previously administered agent

  * Note: Patients with =\< grade 2 neuropathy are an exception to this criterion and may qualify for the study
* REGISTRATION TO TREATMENT (STEP 1): Patients who have received major surgery must have recovered adequately from the toxicity and/or complications from the intervention prior to starting therapy
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have a known additional malignancy that is progressing or requires active treatment; exceptions include basal cell carcinoma of the skin or squamous cell carcinoma of the skin that has undergone potentially curative therapy or in situ cervical cancer
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have known active central nervous system (CNS) metastases and/or carcinomatous meningitis; subjects with previously treated brain metastases may participate provided they are stable (without evidence of progression by imaging for at least four weeks prior to the first dose of protocol treatment and any neurologic symptoms have returned to baseline), have no evidence of new or enlarging brain metastases, and are not using steroids for at least 7 days prior to protocol treatment; this exception does not include carcinomatous meningitis which is excluded regardless of clinical stability
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have active autoimmune disease that has required systemic treatment in the past 2 years (i.e. with use of disease modifying agents, corticosteroids or immunosuppressive drugs); replacement therapy (e.g., thyroxine, insulin, or physiologic corticosteroid replacement therapy for adrenal or pituitary insufficiency, etc.) is not considered a form of systemic treatment
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have known history of, or any evidence of active, non-infectious pneumonitis
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have an active infection requiring systemic therapy
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have a history or current evidence of any condition, therapy, or laboratory abnormality that might confound the results of the trial, interfere with the subject's participation for the full duration of the trial, or is not in the best interest of the subject to participate, in the opinion of the treating investigator
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have received prior therapy with an anti-PD-1, anti-PD-L1, or anti-PD-L2 agent
* REGISTRATION TO TREATMENT (STEP 1): Patients who are Human Immunodeficiency Virus (HIV) positive are eligible if they have undetectable HIV viral load and CD4+ T-cell count ≥ 250/mm3.
* REGISTRATION TO TREATMENT (STEP 1): Patients with a known positive test for Hepatitis C virus ribonucleic acid (HCV antibody) indicating acute or chronic infection might be enrolled if the viral load by PCR is undetectable with/without active treatment.
* REGISTRATION TO TREATMENT (STEP 1): Patients must not have known history of hepatitis B (defined as Hepatitis B surface antigen \[HBsAg\] reactive).
* REGISTRATION TO TREATMENT (STEP 1): Patient must not have received a live vaccine within 30 days of planned start of study therapy

  * NOTE: Seasonal influenza vaccines for injection are generally inactivated flu vaccines and are allowed; however intranasal influenza vaccines (e.g., Flu-Mist) are live attenuated vaccines, and are not allowed
* REGISTRATION TO TREATMENT (STEP 1): Absolute neutrophil count (ANC) \>= 1,500 /mcL, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Platelet count \>= 100,000 /mcL, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Hemoglobin (Hgb) \>= 9 g/dL OR \>= 5.6 mmol/L without transfusion of erythropoietin (EPO) dependency, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Serum creatinine =\< 1.5 X upper limit of normal (ULN) OR creatinine clearance (per institutional standards) \>= 60 mL/min for patient with creatinine levels \> 1.5 X ULN, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Serum total bilirubin =\< 1.5 X ULN OR direct bilirubin

  =\< ULN for subjects with total bilirubin levels \> 1.5 X ULN, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Aspartate aminotransferase (AST) (serum glutamic oxaloacetic transaminase \[SGOT\]) and alanine aminotransferase (ALT) (serum glutamic pyruvic transaminase \[SGPT\]) =\< 2.5 X ULN OR =\< 5 X ULN for subjects with liver metastases, within 14 days prior to first dose of pembrolizumab
* REGISTRATION TO TREATMENT (STEP 1): Patients should not be receiving concomitant strong CYP3A4 inducers or inhibitors ≤ 7 days prior to registration due to their potential to effect the activity or pharmacokinetics of study agents and/or QT interval prolongation toxicity. Should treatment with any of these agents be required, consult with study chair.
* REGISTRATION TO TREATMENT (STEP 1): Patients should not have received prior allogeneic transplant.

**Minimum Age:** 18 Years

**Sex:** ALL

**Standard Ages:**

- ADULT

- OLDER_ADULT

### Contacts Locations Module

#### Locations

**Location 1:**

**City:** Goodyear

**Country:** United States

**Facility:** CTCA at Western Regional Medical Center

**State:** Arizona

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 85338

**Location 2:**

**City:** Phoenix

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 602-406-8222

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Center at Saint Joseph's

**State:** Arizona

**Status:** RECRUITING

**Zip:** 85004

**Location 3:**

**City:** Fort Smith

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 800-378-9373

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Fort Smith

**State:** Arkansas

**Status:** RECRUITING

**Zip:** 72903

**Location 4:**

**City:** Hot Springs

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** CHI Saint Vincent Cancer Center Hot Springs

**State:** Arkansas

**Status:** RECRUITING

**Zip:** 71913

**Location 5:**

**City:** Arroyo Grande

**Contacts:**

***Contact 1:***

- **Email:** research@dignityhealth.org

- **Name:** Site Public Contact

- **Phone:** 916-851-2283

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mission Hope Medical Oncology - Arroyo Grande

**State:** California

**Status:** RECRUITING

**Zip:** 93420

**Location 6:**

**City:** San Luis Obispo

**Contacts:**

***Contact 1:***

- **Email:** Diane.DeVos-Schmidt@DignityHealth.org

- **Name:** Site Public Contact

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Pacific Central Coast Health Center-San Luis Obispo

**State:** California

**Status:** RECRUITING

**Zip:** 93401

**Location 7:**

**City:** Santa Maria

**Contacts:**

***Contact 1:***

- **Email:** research@dignityhealth.org

- **Name:** Site Public Contact

- **Phone:** 916-851-2283

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mission Hope Medical Oncology - Santa Maria

**State:** California

**Status:** RECRUITING

**Zip:** 93444

**Location 8:**

**City:** Colorado Springs

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Penrose-Saint Francis Healthcare

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80907

**Location 9:**

**City:** Colorado Springs

**Contacts:**

***Contact 1:***

- **Email:** info@westernstatesncorp.org

- **Name:** Site Public Contact

- **Phone:** 303-777-2663

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers-Penrose

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80907

**Location 10:**

**City:** Denver

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Porter Adventist Hospital

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80210

**Location 11:**

**City:** Durango

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Medical Center

**State:** Colorado

**Status:** RECRUITING

**Zip:** 81301

**Location 12:**

**City:** Durango

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southwest Oncology PC

**State:** Colorado

**Status:** RECRUITING

**Zip:** 81301

**Location 13:**

**City:** Golden

**Country:** United States

**Facility:** Mountain Blue Cancer Care Center

**State:** Colorado

**Status:** SUSPENDED

**Zip:** 80401

**Location 14:**

**City:** Lakewood

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers-Lakewood

**State:** Colorado

**Status:** SUSPENDED

**Zip:** 80228

**Location 15:**

**City:** Lakewood

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Anthony Hospital

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80228

**Location 16:**

**City:** Littleton

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Littleton Adventist Hospital

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80122

**Location 17:**

**City:** Longmont

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Longmont United Hospital

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80501

**Location 18:**

**City:** Longmont

**Contacts:**

***Contact 1:***

- **Email:** info@westernstatesncorp.org

- **Name:** Site Public Contact

- **Phone:** 303-777-2663

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers-Longmont

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80501

**Location 19:**

**City:** Parker

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Parker Adventist Hospital

**State:** Colorado

**Status:** RECRUITING

**Zip:** 80138

**Location 20:**

**City:** Parker

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers-Parker

**State:** Colorado

**Status:** SUSPENDED

**Zip:** 80138

**Location 21:**

**City:** Pueblo

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Mary Corwin Medical Center

**State:** Colorado

**Status:** RECRUITING

**Zip:** 81004

**Location 22:**

**City:** Pueblo

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers - Pueblo

**State:** Colorado

**Status:** SUSPENDED

**Zip:** 81008

**Location 23:**

**City:** Thornton

**Country:** United States

**Facility:** Rocky Mountain Cancer Centers-Thornton

**State:** Colorado

**Status:** SUSPENDED

**Zip:** 80260

**Location 24:**

**City:** Derby

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital-Derby Care Center

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06418

**Location 25:**

**City:** Fairfield

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital Care Center-Fairfield

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06824

**Location 26:**

**City:** Guilford

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital Care Center - Guiford

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06437

**Location 27:**

**City:** Hartford

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital Care Center at Saint Francis

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06105

**Location 28:**

**City:** New Haven

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Center/Yale-New Haven Hospital

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06510

**Location 29:**

**City:** North Haven

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Yale-New Haven Hospital North Haven Medical Center

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06473

**Location 30:**

**City:** Torrington

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital-Torrington Care Center

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06790

**Location 31:**

**City:** Trumbull

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital Care Center-Trumbull

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06611

**Location 32:**

**City:** Waterbury

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital-Waterbury Care Center

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06708

**Location 33:**

**City:** Waterford

**Contacts:**

***Contact 1:***

- **Email:** canceranswers@yale.edu

- **Name:** Site Public Contact

- **Phone:** 203-785-5702

- **Role:** CONTACT

***Contact 2:***

- **Name:** Amer M. Zeidan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Smilow Cancer Hospital Care Center - Waterford

**State:** Connecticut

**Status:** RECRUITING

**Zip:** 06385

**Location 34:**

**City:** Frankford

**Country:** United States

**Facility:** Beebe South Coastal Health Campus

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19945

**Location 35:**

**City:** Lewes

**Country:** United States

**Facility:** Beebe Medical Center

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19958

**Location 36:**

**City:** Newark

**Country:** United States

**Facility:** Delaware Clinical and Laboratory Physicians PA

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19713

**Location 37:**

**City:** Newark

**Country:** United States

**Facility:** Helen F Graham Cancer Center

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19713

**Location 38:**

**City:** Newark

**Country:** United States

**Facility:** Medical Oncology Hematology Consultants PA

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19713

**Location 39:**

**City:** Newark

**Country:** United States

**Facility:** Christiana Care Health System-Christiana Hospital

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19718

**Location 40:**

**City:** Rehoboth Beach

**Country:** United States

**Facility:** Beebe Health Campus

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19971

**Location 41:**

**City:** Seaford

**Country:** United States

**Facility:** TidalHealth Nanticoke / Allen Cancer Center

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19973

**Location 42:**

**City:** Wilmington

**Country:** United States

**Facility:** Christiana Care Health System-Wilmington Hospital

**State:** Delaware

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19801

**Location 43:**

**City:** Boise

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Alphonsus Cancer Care Center-Boise

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83706

**Location 44:**

**City:** Caldwell

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Alphonsus Cancer Care Center-Caldwell

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83605

**Location 45:**

**City:** Coeur d'Alene

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Kootenai Medical Center

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83814

**Location 46:**

**City:** Emmett

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Walter Knox Memorial Hospital

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83617

**Location 47:**

**City:** Meridian

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Idaho Urologic Institute-Meridian

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83642

**Location 48:**

**City:** Nampa

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Alphonsus Medical Center-Nampa

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83686

**Location 49:**

**City:** Post Falls

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Kootenai Cancer Center

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83854

**Location 50:**

**City:** Sandpoint

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Kootenai Cancer Clinic

**State:** Idaho

**Status:** RECRUITING

**Zip:** 83864

**Location 51:**

**City:** Aurora

**Contacts:**

***Contact 1:***

- **Email:** Cancer.Research@rushcopley.com

- **Name:** Site Public Contact

- **Phone:** 630-978-6212

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Rush - Copley Medical Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 60504

**Location 52:**

**City:** Bloomington

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Bloomington

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61704

**Location 53:**

**City:** Canton

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Canton

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61520

**Location 54:**

**City:** Carbondale

**Contacts:**

***Contact 1:***

- **Email:** clinical.research@sih.net

- **Name:** Site Public Contact

- **Phone:** 618-457-5200

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Memorial Hospital of Carbondale

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62902

**Location 55:**

**City:** Carterville

**Contacts:**

***Contact 1:***

- **Email:** clinical.research@sih.net

- **Name:** Site Public Contact

- **Phone:** 618-985-3333

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** SIH Cancer Institute

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62918

**Location 56:**

**City:** Carthage

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Carthage

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62321

**Location 57:**

**City:** Centralia

**Contacts:**

***Contact 1:***

- **Email:** rhamrick@dmhhs.org

- **Name:** Site Public Contact

- **Phone:** 217-876-4740

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Centralia Oncology Clinic

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62801

**Location 58:**

**City:** Chicago

**Contacts:**

***Contact 1:***

- **Email:** cancer@northwestern.edu

- **Name:** Site Public Contact

- **Phone:** 312-695-1301

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jessica K. Altman

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Northwestern University

**State:** Illinois

**Status:** RECRUITING

**Zip:** 60611

**Location 59:**

**City:** Chicago

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 312-355-3046

- **Role:** CONTACT

***Contact 2:***

- **Name:** Irum Khan

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** University of Illinois

**State:** Illinois

**Status:** RECRUITING

**Zip:** 60612

**Location 60:**

**City:** Danville

**Contacts:**

***Contact 1:***

- **Email:** Research@carle.com

- **Name:** Site Public Contact

- **Phone:** 800-446-5532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Carle on Vermilion

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61832

**Location 61:**

**City:** Decatur

**Contacts:**

***Contact 1:***

- **Email:** rhamrick@dmhhs.org

- **Name:** Site Public Contact

- **Phone:** 217-876-4740

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Care Specialists of Illinois - Decatur

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62526

**Location 62:**

**City:** Decatur

**Contacts:**

***Contact 1:***

- **Email:** rhamrick@dmhhs.org

- **Name:** Site Public Contact

- **Phone:** 217-876-4740

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Decatur Memorial Hospital

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62526

**Location 63:**

**City:** Dixon

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 815-285-7800

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Dixon

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61021

**Location 64:**

**City:** Effingham

**Contacts:**

***Contact 1:***

- **Email:** Research@carle.com

- **Name:** Site Public Contact

- **Phone:** 800-446-5532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Carle Physician Group-Effingham

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62401

**Location 65:**

**City:** Effingham

**Contacts:**

***Contact 1:***

- **Email:** rhamrick@dmhhs.org

- **Name:** Site Public Contact

- **Phone:** 217-876-4740

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Crossroads Cancer Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62401

**Location 66:**

**City:** Eureka

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Eureka

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61530

**Location 67:**

**City:** Galesburg

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Galesburg

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61401

**Location 68:**

**City:** Galesburg

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 309-344-2831

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Western Illinois Cancer Treatment Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61401

**Location 69:**

**City:** Kewanee

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Kewanee Clinic

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61443

**Location 70:**

**City:** Lake Forest

**Contacts:**

***Contact 1:***

- **Email:** cancertrials@northwestern.edu

- **Name:** Site Public Contact

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jessica K. Altman

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Northwestern Medicine Lake Forest Hospital

**State:** Illinois

**Status:** RECRUITING

**Zip:** 60045

**Location 71:**

**City:** Macomb

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Macomb

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61455

**Location 72:**

**City:** Mattoon

**Contacts:**

***Contact 1:***

- **Email:** Research@carle.com

- **Name:** Site Public Contact

- **Phone:** 800-446-5532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Carle Physician Group-Mattoon/Charleston

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61938

**Location 73:**

**City:** Mount Vernon

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 618-242-4600

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Good Samaritan Regional Health Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62864

**Location 74:**

**City:** O'Fallon

**Contacts:**

***Contact 1:***

- **Email:** morganthaler.jodi@mhsil.com

- **Name:** Site Public Contact

- **Phone:** 217-876-4762

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Care Center of O'Fallon

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62269

**Location 75:**

**City:** Ottawa

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Ottawa Clinic

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61350

**Location 76:**

**City:** Pekin

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Pekin

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61554

**Location 77:**

**City:** Peoria

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Peoria

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61615

**Location 78:**

**City:** Peoria

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Methodist Medical Center of Illinois

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61636

**Location 79:**

**City:** Peru

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Peru

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61354

**Location 80:**

**City:** Peru

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 815-664-4141

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Valley Radiation Oncology

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61354

**Location 81:**

**City:** Princeton

**Contacts:**

***Contact 1:***

- **Email:** andersonj@illinoiscancercare.com

- **Name:** Site Public Contact

- **Phone:** 309-243-3605

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Illinois CancerCare-Princeton

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61356

**Location 82:**

**City:** Springfield

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 217-545-7929

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southern Illinois University School of Medicine

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62702

**Location 83:**

**City:** Springfield

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 800-444-7541

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Springfield Clinic

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62702

**Location 84:**

**City:** Springfield

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 217-788-3528

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Memorial Medical Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 62781

**Location 85:**

**City:** Swansea

**Country:** United States

**Facility:** Southwest Illinois Health Services LLP

**State:** Illinois

**Status:** SUSPENDED

**Zip:** 62226

**Location 86:**

**City:** Urbana

**Contacts:**

***Contact 1:***

- **Email:** Research@carle.com

- **Name:** Site Public Contact

- **Phone:** 800-446-5532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Carle Cancer Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61801

**Location 87:**

**City:** Urbana

**Contacts:**

***Contact 1:***

- **Email:** Research@carle.com

- **Name:** Site Public Contact

- **Phone:** 800-446-5532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** The Carle Foundation Hospital

**State:** Illinois

**Status:** RECRUITING

**Zip:** 61801

**Location 88:**

**City:** Yorkville

**Contacts:**

***Contact 1:***

- **Email:** Cancer.Research@rushcopley.com

- **Name:** Site Public Contact

- **Phone:** 630-978-6212

- **Role:** CONTACT

***Contact 2:***

- **Name:** Priyank P. Patel

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Rush-Copley Healthcare Center

**State:** Illinois

**Status:** RECRUITING

**Zip:** 60560

**Location 89:**

**City:** Ames

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-956-4132

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mary Greeley Medical Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50010

**Location 90:**

**City:** Ames

**Contacts:**

***Contact 1:***

- **Email:** ksoder@mcfarlandclinic.com

- **Name:** Site Public Contact

- **Phone:** 515-239-4734

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** McFarland Clinic PC - Ames

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50010

**Location 91:**

**City:** Boone

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-956-4132

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** McFarland Clinic PC-Boone

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50036

**Location 92:**

**City:** Clive

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Medical Oncology and Hematology Associates-West Des Moines

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50325

**Location 93:**

**City:** Clive

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Cancer Center-West Lakes

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50325

**Location 94:**

**City:** Council Bluffs

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Alegent Health Mercy Hospital

**State:** Iowa

**Status:** RECRUITING

**Zip:** 51503

**Location 95:**

**City:** Creston

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Greater Regional Medical Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50801

**Location 96:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-241-6727

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Iowa Methodist Medical Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50309

**Location 97:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-282-2921

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Medical Oncology and Hematology Associates-Des Moines

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50309

**Location 98:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-282-2200

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Broadlawns Medical Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50314

**Location 99:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Medical Oncology and Hematology Associates-Laurel

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50314

**Location 100:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Medical Center - Des Moines

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50314

**Location 101:**

**City:** Des Moines

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-241-8704

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Iowa Lutheran Hospital

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50316

**Location 102:**

**City:** Fort Dodge

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-956-4132

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** McFarland Clinic PC-Trinity Cancer Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50501

**Location 103:**

**City:** Fort Dodge

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-574-8302

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Trinity Regional Medical Center

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50501

**Location 104:**

**City:** Jefferson

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-956-4132

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** McFarland Clinic PC-Jefferson

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50129

**Location 105:**

**City:** Marshalltown

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-956-4132

- **Role:** CONTACT

***Contact 2:***

- **Name:** Debra M. Prow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** McFarland Clinic PC-Marshalltown

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50158

**Location 106:**

**City:** West Des Moines

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 515-343-1000

- **Role:** CONTACT

***Contact 2:***

- **Name:** Robert J. Behrens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Methodist West Hospital

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50266-7700

**Location 107:**

**City:** West Des Moines

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Medical Center-West Lakes

**State:** Iowa

**Status:** RECRUITING

**Zip:** 50266

**Location 108:**

**City:** Lawrence

**Country:** United States

**Facility:** Lawrence Memorial Hospital

**State:** Kansas

**Status:** SUSPENDED

**Zip:** 66044

**Location 109:**

**City:** Wichita

**Contacts:**

***Contact 1:***

- **Email:** Keisha.humphries@ascension.org

- **Name:** Site Public Contact

- **Phone:** 316-268-5374

- **Role:** CONTACT

***Contact 2:***

- **Name:** Shaker R. Dakhil

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Center of Kansas-Wichita Medical Arts Tower

**State:** Kansas

**Status:** RECRUITING

**Zip:** 67208

**Location 110:**

**City:** Wichita

**Contacts:**

***Contact 1:***

- **Email:** Keisha.humphries@ascension.org

- **Name:** Site Public Contact

- **Phone:** 800-362-0070

- **Role:** CONTACT

***Contact 2:***

- **Name:** Shaker R. Dakhil

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Ascension Via Christi Hospitals Wichita

**State:** Kansas

**Status:** RECRUITING

**Zip:** 67214

**Location 111:**

**City:** Wichita

**Contacts:**

***Contact 1:***

- **Email:** Keisha.humphries@ascension.org

- **Name:** Site Public Contact

- **Phone:** 316-268-5374

- **Role:** CONTACT

***Contact 2:***

- **Name:** Shaker R. Dakhil

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Center of Kansas - Wichita

**State:** Kansas

**Status:** RECRUITING

**Zip:** 67214

**Location 112:**

**City:** Wichita

**Contacts:**

***Contact 1:***

- **Email:** Keisha.humphries@ascension.org

- **Name:** Site Public Contact

- **Phone:** 316-268-5374

- **Role:** CONTACT

***Contact 2:***

- **Name:** Shaker R. Dakhil

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Wesley Medical Center

**State:** Kansas

**Status:** RECRUITING

**Zip:** 67214

**Location 113:**

**City:** Bardstown

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Flaget Memorial Hospital

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40004

**Location 114:**

**City:** Corbin

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Commonwealth Cancer Center-Corbin

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40701

**Location 115:**

**City:** Lexington

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Joseph Radiation Oncology Resource Center

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40504

**Location 116:**

**City:** Lexington

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Joseph Hospital East

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40509

**Location 117:**

**City:** London

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Joseph London

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40741

**Location 118:**

**City:** Louisville

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Jewish Hospital

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40202

**Location 119:**

**City:** Louisville

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saints Mary and Elizabeth Hospital

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40215

**Location 120:**

**City:** Louisville

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Jewish Hospital Medical Center Northeast

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40245

**Location 121:**

**City:** Shepherdsville

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Jewish Hospital Medical Center South

**State:** Kentucky

**Status:** RECRUITING

**Zip:** 40165

**Location 122:**

**City:** Baltimore

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 410-368-2910

- **Role:** CONTACT

***Contact 2:***

- **Name:** Carole B. Miller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Agnes Hospital

**State:** Maryland

**Status:** RECRUITING

**Zip:** 21229

**Location 123:**

**City:** Adrian

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 517-265-0116

- **Role:** CONTACT

***Contact 2:***

- **Name:** Rex B. Mowat

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Hickman Cancer Center

**State:** Michigan

**Status:** RECRUITING

**Zip:** 49221

**Location 124:**

**City:** Monroe

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 800-444-3561

- **Role:** CONTACT

***Contact 2:***

- **Name:** Rex B. Mowat

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Toledo Clinic Cancer Centers-Monroe

**State:** Michigan

**Status:** RECRUITING

**Zip:** 48162

**Location 125:**

**City:** Rochester

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 855-776-0015

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mark R. Litzow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mayo Clinic in Rochester

**State:** Minnesota

**Status:** RECRUITING

**Zip:** 55905

**Location 126:**

**City:** Saint Cloud

**Contacts:**

***Contact 1:***

- **Email:** coborncancercenter@centracare.com

- **Name:** Site Public Contact

- **Phone:** 877-229-4907

- **Role:** CONTACT

***Contact 2:***

- **Name:** Donald J. Jurgens

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Coborn Cancer Center at Saint Cloud Hospital

**State:** Minnesota

**Status:** RECRUITING

**Zip:** 56303

**Location 127:**

**City:** Ballwin

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-251-7058

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Louis Cancer and Breast Institute-Ballwin

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63011

**Location 128:**

**City:** Bonne Terre

**Country:** United States

**Facility:** Parkland Health Center-Bonne Terre

**State:** Missouri

**Status:** SUSPENDED

**Zip:** 63628

**Location 129:**

**City:** Branson

**Country:** United States

**Facility:** Cox Cancer Center Branson

**State:** Missouri

**Status:** SUSPENDED

**Zip:** 65616

**Location 130:**

**City:** Cape Girardeau

**Contacts:**

***Contact 1:***

- **Email:** sfmc@sfmc.net

- **Name:** Site Public Contact

- **Phone:** 573-334-2230

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Francis Medical Center

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63703

**Location 131:**

**City:** Cape Girardeau

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 573-651-5550

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southeast Cancer Center

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63703

**Location 132:**

**City:** Farmington

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-996-5569

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Parkland Health Center - Farmington

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63640

**Location 133:**

**City:** Jefferson City

**Contacts:**

***Contact 1:***

- **Email:** swooden@mail.crmc.org

- **Name:** Site Public Contact

- **Phone:** 573-632-4814

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Capital Region Southwest Campus

**State:** Missouri

**Status:** RECRUITING

**Zip:** 65109

**Location 134:**

**City:** Joplin

**Contacts:**

***Contact 1:***

- **Email:** LJCrockett@freemanhealth.com

- **Name:** Site Public Contact

- **Phone:** 417-347-4030

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Freeman Health System

**State:** Missouri

**Status:** RECRUITING

**Zip:** 64804

**Location 135:**

**City:** Joplin

**Contacts:**

***Contact 1:***

- **Email:** esmeralda.carrillo@mercy.net

- **Name:** Site Public Contact

- **Phone:** 417-556-3074

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Joplin

**State:** Missouri

**Status:** RECRUITING

**Zip:** 64804

**Location 136:**

**City:** Rolla

**Contacts:**

***Contact 1:***

- **Email:** kaysmith@phelpshealth.org

- **Name:** Site Public Contact

- **Phone:** 573-458-8776

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Delbert Day Cancer Institute at PCRMC

**State:** Missouri

**Status:** RECRUITING

**Zip:** 65401

**Location 137:**

**City:** Rolla

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 573-458-6379

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Clinic-Rolla-Cancer and Hematology

**State:** Missouri

**Status:** RECRUITING

**Zip:** 65401

**Location 138:**

**City:** Saint Joseph

**Contacts:**

***Contact 1:***

- **Email:** linda.schumacher@mymlc.com

- **Name:** Site Public Contact

- **Phone:** 816-271-7937

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Heartland Regional Medical Center

**State:** Missouri

**Status:** RECRUITING

**Zip:** 64506

**Location 139:**

**City:** Saint Louis

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-353-1870

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Louis Cancer and Breast Institute-South City

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63109

**Location 140:**

**City:** Saint Louis

**Contacts:**

***Contact 1:***

- **Email:** janet.lesko@mercy.net

- **Name:** Site Public Contact

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital South

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63128

**Location 141:**

**City:** Saint Louis

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-996-5569

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Missouri Baptist Medical Center

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63131

**Location 142:**

**City:** Saint Louis

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-251-7066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Saint Louis

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63141

**Location 143:**

**City:** Sainte Genevieve

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-996-5569

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Sainte Genevieve County Memorial Hospital

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63670

**Location 144:**

**City:** Springfield

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 417-269-4520

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Springfield

**State:** Missouri

**Status:** RECRUITING

**Zip:** 65804

**Location 145:**

**City:** Springfield

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 417-269-4520

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** CoxHealth South Hospital

**State:** Missouri

**Status:** RECRUITING

**Zip:** 65807

**Location 146:**

**City:** Sullivan

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-996-5569

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Missouri Baptist Sullivan Hospital

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63080

**Location 147:**

**City:** Sunset Hills

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 314-996-5569

- **Role:** CONTACT

***Contact 2:***

- **Name:** Bryan A. Faller

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Missouri Baptist Outpatient Center-Sunset Hills

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63127

**Location 148:**

**City:** Washington

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 636-390-1600

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Washington

**State:** Missouri

**Status:** RECRUITING

**Zip:** 63090

**Location 149:**

**City:** Anaconda

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Community Hospital of Anaconda

**State:** Montana

**Status:** RECRUITING

**Zip:** 59711

**Location 150:**

**City:** Billings

**Contacts:**

***Contact 1:***

- **Email:** research@billingsclinic.org

- **Name:** Site Public Contact

- **Phone:** 800-996-2663

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Billings Clinic Cancer Center

**State:** Montana

**Status:** RECRUITING

**Zip:** 59101

**Location 151:**

**City:** Bozeman

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Bozeman Deaconess Hospital

**State:** Montana

**Status:** RECRUITING

**Zip:** 59715

**Location 152:**

**City:** Great Falls

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Benefis Healthcare- Sletten Cancer Institute

**State:** Montana

**Status:** RECRUITING

**Zip:** 59405

**Location 153:**

**City:** Great Falls

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Great Falls Clinic

**State:** Montana

**Status:** RECRUITING

**Zip:** 59405

**Location 154:**

**City:** Helena

**Country:** United States

**Facility:** Saint Peter's Community Hospital

**State:** Montana

**Status:** SUSPENDED

**Zip:** 59601

**Location 155:**

**City:** Kalispell

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Kalispell Regional Medical Center

**State:** Montana

**Status:** RECRUITING

**Zip:** 59901

**Location 156:**

**City:** Missoula

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Community Medical Hospital

**State:** Montana

**Status:** RECRUITING

**Zip:** 59804

**Location 157:**

**City:** Bellevue

**Contacts:**

***Contact 1:***

- **Email:** unmcrsa@unmc.edu

- **Name:** Site Public Contact

- **Phone:** 402-559-6941

- **Role:** CONTACT

***Contact 2:***

- **Name:** Vijaya R. Bhatt

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Nebraska Medicine-Bellevue

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68123

**Location 158:**

**City:** Grand Island

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** CHI Health Saint Francis

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68803

**Location 159:**

**City:** Kearney

**Country:** United States

**Facility:** Heartland Hematology and Oncology

**State:** Nebraska

**Status:** SUSPENDED

**Zip:** 68845

**Location 160:**

**City:** Kearney

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** CHI Health Good Samaritan

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68847

**Location 161:**

**City:** Lincoln

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Elizabeth Regional Medical Center

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68510

**Location 162:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 402-559-5600

- **Role:** CONTACT

***Contact 2:***

- **Name:** Vijaya R. Bhatt

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Nebraska Medicine-Village Pointe

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68118

**Location 163:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Alegent Health Immanuel Medical Center

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68122

**Location 164:**

**City:** Omaha

**Country:** United States

**Facility:** Hematology and Oncology Consultants PC

**State:** Nebraska

**Status:** SUSPENDED

**Zip:** 68122

**Location 165:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Alegent Health Bergan Mercy Medical Center

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68124

**Location 166:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Alegent Health Lakeside Hospital

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68130

**Location 167:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Creighton University Medical Center

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68131

**Location 168:**

**City:** Omaha

**Contacts:**

***Contact 1:***

- **Email:** unmcrsa@unmc.edu

- **Name:** Site Public Contact

- **Phone:** 402-559-6941

- **Role:** CONTACT

***Contact 2:***

- **Name:** Vijaya R. Bhatt

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** University of Nebraska Medical Center

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68198

**Location 169:**

**City:** Papillion

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Midlands Community Hospital

**State:** Nebraska

**Status:** RECRUITING

**Zip:** 68046

**Location 170:**

**City:** Morristown

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 973-971-5900

- **Role:** CONTACT

***Contact 2:***

- **Name:** Charles M. Farber

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Morristown Medical Center

**State:** New Jersey

**Status:** RECRUITING

**Zip:** 07960

**Location 171:**

**City:** Middletown

**Contacts:**

***Contact 1:***

- **Email:** jgerlach@garnethealth.org

- **Name:** Site Public Contact

- **Phone:** 845-333-1133

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey M. Stewart

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Garnet Health Medical Center

**State:** New York

**Status:** RECRUITING

**Zip:** 10940

**Location 172:**

**City:** Clinton

**Contacts:**

***Contact 1:***

- **Email:** jfields@cancersmoc.com

- **Name:** Site Public Contact

- **Phone:** 919-587-9084

- **Role:** CONTACT

***Contact 2:***

- **Name:** Samer S. Kasbari

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southeastern Medical Oncology Center-Clinton

**State:** North Carolina

**Status:** RECRUITING

**Zip:** 28328

**Location 173:**

**City:** Goldsboro

**Contacts:**

***Contact 1:***

- **Email:** jfields@cancersmoc.com

- **Name:** Site Public Contact

- **Phone:** 919-587-9084

- **Role:** CONTACT

***Contact 2:***

- **Name:** Samer S. Kasbari

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southeastern Medical Oncology Center-Goldsboro

**State:** North Carolina

**Status:** RECRUITING

**Zip:** 27534

**Location 174:**

**City:** Goldsboro

**Country:** United States

**Facility:** Wayne Memorial Hospital

**State:** North Carolina

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 27534

**Location 175:**

**City:** Jacksonville

**Country:** United States

**Facility:** Onslow Memorial Hospital

**State:** North Carolina

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 28546

**Location 176:**

**City:** Jacksonville

**Contacts:**

***Contact 1:***

- **Email:** jfields@cancersmoc.com

- **Name:** Site Public Contact

- **Phone:** 910-587-9084

- **Role:** CONTACT

***Contact 2:***

- **Name:** Samer S. Kasbari

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Southeastern Medical Oncology Center-Jacksonville

**State:** North Carolina

**Status:** RECRUITING

**Zip:** 28546

**Location 177:**

**City:** Cincinnati

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Good Samaritan Hospital - Cincinnati

**State:** Ohio

**Status:** RECRUITING

**Zip:** 45220

**Location 178:**

**City:** Cincinnati

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Bethesda North Hospital

**State:** Ohio

**Status:** RECRUITING

**Zip:** 45242

**Location 179:**

**City:** Cincinnati

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** TriHealth Cancer Institute-Westside

**State:** Ohio

**Status:** RECRUITING

**Zip:** 45247

**Location 180:**

**City:** Cincinnati

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** TriHealth Cancer Institute-Anderson

**State:** Ohio

**Status:** RECRUITING

**Zip:** 45255

**Location 181:**

**City:** Cleveland

**Contacts:**

***Contact 1:***

- **Email:** dstrater@metrohealth.org

- **Name:** Site Public Contact

- **Phone:** 216-778-8526

- **Role:** CONTACT

***Contact 2:***

- **Name:** William Tse

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** MetroHealth Medical Center

**State:** Ohio

**Status:** RECRUITING

**Zip:** 44109

**Location 182:**

**City:** Perrysburg

**Country:** United States

**Facility:** Mercy Health Perrysburg Cancer Center

**State:** Ohio

**Status:** SUSPENDED

**Zip:** 43551

**Location 183:**

**City:** Toledo

**Contacts:**

***Contact 1:***

- **Email:** sheree@columbusccop.org

- **Name:** Site Public Contact

- **Phone:** 614-488-2118

- **Role:** CONTACT

***Contact 2:***

- **Name:** Rex B. Mowat

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Health - Saint Anne Hospital

**State:** Ohio

**Status:** RECRUITING

**Zip:** 43623

**Location 184:**

**City:** Toledo

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 800-444-3561

- **Role:** CONTACT

***Contact 2:***

- **Name:** Rex B. Mowat

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Toledo Clinic Cancer Centers-Toledo

**State:** Ohio

**Status:** RECRUITING

**Zip:** 43623

**Location 185:**

**City:** Lawton

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 877-231-4440

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mohamad Khawandanah

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Cancer Centers of Southwest Oklahoma Research

**State:** Oklahoma

**Status:** RECRUITING

**Zip:** 73505

**Location 186:**

**City:** Oklahoma City

**Contacts:**

***Contact 1:***

- **Email:** ou-clinical-trials@ouhsc.edu

- **Name:** Site Public Contact

- **Phone:** 405-271-8777

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mohamad Khawandanah

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** University of Oklahoma Health Sciences Center

**State:** Oklahoma

**Status:** RECRUITING

**Zip:** 73104

**Location 187:**

**City:** Oklahoma City

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 405-752-3402

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jay W. Carlson

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mercy Hospital Oklahoma City

**State:** Oklahoma

**Status:** RECRUITING

**Zip:** 73120

**Location 188:**

**City:** Tulsa

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 918-505-3200

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mohamad Khawandanah

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Oklahoma Cancer Specialists and Research Institute-Tulsa

**State:** Oklahoma

**Status:** RECRUITING

**Zip:** 74146

**Location 189:**

**City:** Baker City

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Alphonsus Medical Center-Baker City

**State:** Oregon

**Status:** RECRUITING

**Zip:** 97814

**Location 190:**

**City:** Ontario

**Contacts:**

***Contact 1:***

- **Email:** stephanie.couch@stjoeshealth.org

- **Name:** Site Public Contact

- **Phone:** 734-712-3671

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Alphonsus Medical Center-Ontario

**State:** Oregon

**Status:** RECRUITING

**Zip:** 97914

**Location 191:**

**City:** Chadds Ford

**Country:** United States

**Facility:** Christiana Care Health System-Concord Health Center

**State:** Pennsylvania

**Status:** ACTIVE_NOT_RECRUITING

**Zip:** 19317

**Location 192:**

**City:** Danville

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-271-5251

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Medical Center

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 17822

**Location 193:**

**City:** Hazleton

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-459-2901

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Medical Center-Cancer Center Hazleton

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 18201

**Location 194:**

**City:** Lewisburg

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-374-8555

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Medical Oncology-Lewisburg

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 17837

**Location 195:**

**City:** Lewistown

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 717-242-7703

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Lewistown Hospital

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 17044

**Location 196:**

**City:** Pottsville

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 800-275-6401

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Cancer Services-Pottsville

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 17901

**Location 197:**

**City:** Scranton

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-703-4768

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Community Medical Center

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 18510

**Location 198:**

**City:** Selinsgrove

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-374-8555

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Medical Oncology-Selinsgrove

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 17870

**Location 199:**

**City:** State College

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-271-5251

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Medical Group

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 16801

**Location 200:**

**City:** Wilkes-Barre

**Contacts:**

***Contact 1:***

- **Email:** HemonCCTrials@geisinger.edu

- **Name:** Site Public Contact

- **Phone:** 570-271-5251

- **Role:** CONTACT

***Contact 2:***

- **Name:** Joseph J. Vadakara

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Geisinger Wyoming Valley/Henry Cancer Center

**State:** Pennsylvania

**Status:** RECRUITING

**Zip:** 18711

**Location 201:**

**City:** Boiling Springs

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Spartanburg

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29316

**Location 202:**

**City:** Clinton

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Laurens

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29325

**Location 203:**

**City:** Easley

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Easley

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29640

**Location 204:**

**City:** Greenville

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** BI-LO Charities Children's Cancer Center

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29605

**Location 205:**

**City:** Greenville

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Butternut

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29605

**Location 206:**

**City:** Greenville

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Faris

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29605

**Location 207:**

**City:** Greenville

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Greenville Memorial Hospital

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29605

**Location 208:**

**City:** Greenville

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Eastside

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29615

**Location 209:**

**City:** Greer

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Greer

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29650

**Location 210:**

**City:** Seneca

**Contacts:**

***Contact 1:***

- **Email:** kim.williams3@prismahealth.org

- **Name:** Site Public Contact

- **Phone:** 864-522-2066

- **Role:** CONTACT

***Contact 2:***

- **Name:** Jeffrey K. Giguere

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Prisma Health Cancer Institute - Seneca

**State:** South Carolina

**Status:** RECRUITING

**Zip:** 29672

**Location 211:**

**City:** Chattanooga

**Country:** United States

**Facility:** Memorial Hospital

**State:** Tennessee

**Status:** SUSPENDED

**Zip:** 37404

**Location 212:**

**City:** Hixson

**Country:** United States

**Facility:** Pulmonary Medicine Center of Chattanooga-Hixson

**State:** Tennessee

**Status:** SUSPENDED

**Zip:** 37343

**Location 213:**

**City:** Ooltewah

**Country:** United States

**Facility:** Memorial GYN Plus

**State:** Tennessee

**Status:** SUSPENDED

**Zip:** 37363

**Location 214:**

**City:** Bryan

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Joseph Regional Cancer Center

**State:** Texas

**Status:** RECRUITING

**Zip:** 77802

**Location 215:**

**City:** Martinsville

**Contacts:**

***Contact 1:***

- **Email:** sharon.hubbard@lpnt.net

- **Name:** Site Public Contact

- **Phone:** 276-666-7489

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mohammed Saad

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Sovah Health Martinsville

**State:** Virginia

**Status:** RECRUITING

**Zip:** 24115

**Location 216:**

**City:** Bremerton

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Harrison HealthPartners Hematology and Oncology-Bremerton

**State:** Washington

**Status:** RECRUITING

**Zip:** 98310

**Location 217:**

**City:** Bremerton

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Harrison Medical Center

**State:** Washington

**Status:** RECRUITING

**Zip:** 98310

**Location 218:**

**City:** Burien

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Highline Medical Center-Main Campus

**State:** Washington

**Status:** RECRUITING

**Zip:** 98166

**Location 219:**

**City:** Enumclaw

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Elizabeth Hospital

**State:** Washington

**Status:** RECRUITING

**Zip:** 98022

**Location 220:**

**City:** Federal Way

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Francis Hospital

**State:** Washington

**Status:** RECRUITING

**Zip:** 98003

**Location 221:**

**City:** Lakewood

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Saint Clare Hospital

**State:** Washington

**Status:** RECRUITING

**Zip:** 98499

**Location 222:**

**City:** Poulsbo

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Harrison HealthPartners Hematology and Oncology-Poulsbo

**State:** Washington

**Status:** RECRUITING

**Zip:** 98370

**Location 223:**

**City:** Tacoma

**Contacts:**

***Contact 1:***

- **Email:** clinicaltrials@sfmc-gi.org

- **Name:** Site Public Contact

- **Phone:** 308-398-6518

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Franciscan Research Center-Northwest Medical Plaza

**State:** Washington

**Status:** RECRUITING

**Zip:** 98405

**Location 224:**

**City:** Tacoma

**Contacts:**

***Contact 1:***

- **Email:** research@southsoundcare.org

- **Name:** Site Public Contact

- **Phone:** 253-306-0532

- **Role:** CONTACT

***Contact 2:***

- **Name:** Richard L. Deming

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Northwest Medical Specialties PLLC

**State:** Washington

**Status:** RECRUITING

**Zip:** 98405

**Location 225:**

**City:** Morgantown

**Contacts:**

***Contact 1:***

- **Email:** cancertrialsinfo@hsc.wvu.edu

- **Name:** Site Public Contact

- **Phone:** 304-293-7374

- **Role:** CONTACT

***Contact 2:***

- **Name:** Kelly G. Ross

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** West Virginia University Healthcare

**State:** West Virginia

**Status:** RECRUITING

**Zip:** 26506

**Location 226:**

**City:** Eau Claire

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Medical Center-EC Cancer Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54701

**Location 227:**

**City:** Eau Claire

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 855-776-0015

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mark R. Litzow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mayo Clinic Health System-Eau Claire Clinic

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54701

**Location 228:**

**City:** Eau Claire

**Contacts:**

***Contact 1:***

- **Name:** Site Public Contact

- **Phone:** 855-776-0015

- **Role:** CONTACT

***Contact 2:***

- **Name:** Mark R. Litzow

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Mayo Clinic Health System Eau Claire Hospital-Luther Campus

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54703

**Location 229:**

**City:** Ladysmith

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Clinic - Ladysmith Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54848

**Location 230:**

**City:** Marshfield

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Medical Center-Marshfield

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54449

**Location 231:**

**City:** Minocqua

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Clinic-Minocqua Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54548

**Location 232:**

**City:** Rice Lake

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Medical Center-Rice Lake

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54868

**Location 233:**

**City:** Stevens Point

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Clinic Stevens Point Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54482

**Location 234:**

**City:** Wausau

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Clinic-Wausau Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54401

**Location 235:**

**City:** Weston

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Medical Center - Weston

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54476

**Location 236:**

**City:** Wisconsin Rapids

**Contacts:**

***Contact 1:***

- **Email:** oncology.clinical.trials@marshfieldresearch.org

- **Name:** Site Public Contact

- **Phone:** 800-782-8581

- **Role:** CONTACT

***Contact 2:***

- **Name:** Ali W. Bseiso

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Marshfield Clinic - Wisconsin Rapids Center

**State:** Wisconsin

**Status:** RECRUITING

**Zip:** 54494

**Location 237:**

**City:** Cody

**Contacts:**

***Contact 1:***

- **Email:** research@billingsclinic.org

- **Name:** Site Public Contact

- **Phone:** 800-996-2663

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Billings Clinic-Cody

**State:** Wyoming

**Status:** RECRUITING

**Zip:** 82414

**Location 238:**

**City:** Sheridan

**Contacts:**

***Contact 1:***

- **Email:** mccinfo@mtcancer.org

- **Name:** Site Public Contact

- **Phone:** 406-969-6060

- **Role:** CONTACT

***Contact 2:***

- **Name:** John M. Schallenkamp

- **Role:** PRINCIPAL_INVESTIGATOR

**Country:** United States

**Facility:** Welch Cancer Center

**State:** Wyoming

**Status:** RECRUITING

**Zip:** 82801

#### Overall Officials

**Official 1:**

**Affiliation:** ECOG-ACRIN Cancer Research Group

**Name:** Amer Zeidan

**Role:** PRINCIPAL_INVESTIGATOR

## Derived Section

### Condition Browse Module - Ancestors

- ID: D000009370

- Term: Neoplasms by Histologic Type

- ID: D000009369

- Term: Neoplasms

- ID: D000006402

- Term: Hematologic Diseases

- ID: D000009196

- Term: Myeloproliferative Disorders

- ID: D000001855

- Term: Bone Marrow Diseases

- ID: D000002908

- Term: Chronic Disease

- ID: D000020969

- Term: Disease Attributes

- ID: D000010335

- Term: Pathologic Processes

- ID: D000009385

- Term: Neoplastic Processes

### Condition Browse Module - Browse Branches

- Abbrev: BC04

- Name: Neoplasms

- Abbrev: BC15

- Name: Blood and Lymph Conditions

- Abbrev: All

- Name: All Conditions

- Abbrev: BC23

- Name: Symptoms and General Pathology

- Abbrev: Rare

- Name: Rare Diseases

### Condition Browse Module - Browse Leaves

- ID: M10945

- Name: Leukemia

- Relevance: HIGH

- As Found: Leukemia

- ID: M10955

- Name: Leukemia, Myeloid

- Relevance: HIGH

- As Found: Myelogenous Leukemia

- ID: M18123

- Name: Leukemia, Myelogenous, Chronic, BCR-ABL Positive

- Relevance: HIGH

- As Found: Chronic Myelogenous Leukemia, BCR-ABL1 Positive

- ID: M18125

- Name: Leukemia, Myeloid, Chronic-Phase

- Relevance: HIGH

- As Found: Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive

- ID: M20497

- Name: Neoplasm, Residual

- Relevance: HIGH

- As Found: Minimal Residual Disease

- ID: M12315

- Name: Neoplasms by Histologic Type

- Relevance: LOW

- As Found: Unknown

- ID: M9490

- Name: Hematologic Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M12149

- Name: Myeloproliferative Disorders

- Relevance: LOW

- As Found: Unknown

- ID: M5134

- Name: Bone Marrow Diseases

- Relevance: LOW

- As Found: Unknown

- ID: M6147

- Name: Chronic Disease

- Relevance: LOW

- As Found: Unknown

- ID: M22700

- Name: Disease Attributes

- Relevance: LOW

- As Found: Unknown

- ID: M12330

- Name: Neoplastic Processes

- Relevance: LOW

- As Found: Unknown

- ID: T3995

- Name: Myeloid Leukemia

- Relevance: HIGH

- As Found: Myeloid Leukemia

- ID: T1303

- Name: Chronic Graft Versus Host Disease

- Relevance: HIGH

- As Found: Chronic

- ID: T1309

- Name: Chronic Myeloid Leukemia

- Relevance: HIGH

- As Found: Chronic Myeloid Leukemia

- ID: T1311

- Name: Chronic Myeloproliferative Disorders

- Relevance: LOW

- As Found: Unknown

### Condition Browse Module - Meshes

- ID: D000007938

- Term: Leukemia

- ID: D000007951

- Term: Leukemia, Myeloid

- ID: D000015464

- Term: Leukemia, Myelogenous, Chronic, BCR-ABL Positive

- ID: D000018365

- Term: Neoplasm, Residual

- ID: D000015466

- Term: Leukemia, Myeloid, Chronic-Phase

### Intervention Browse Module - Ancestors

- ID: D000074322

- Term: Antineoplastic Agents, Immunological

- ID: D000000970

- Term: Antineoplastic Agents

- ID: D000082082

- Term: Immune Checkpoint Inhibitors

- ID: D000045504

- Term: Molecular Mechanisms of Pharmacological Action

- ID: D000092004

- Term: Tyrosine Kinase Inhibitors

- ID: D000047428

- Term: Protein Kinase Inhibitors

- ID: D000004791

- Term: Enzyme Inhibitors

### Intervention Browse Module - Browse Branches

- Abbrev: ANeo

- Name: Antineoplastic Agents

- Abbrev: All

- Name: All Drugs and Chemicals

- Abbrev: AA

- Name: Amino Acids

### Intervention Browse Module - Browse Leaves

- ID: M349416

- Name: Pembrolizumab

- Relevance: HIGH

- As Found: Blind

- ID: M145649

- Name: Nilotinib

- Relevance: HIGH

- As Found: Cross-sectional

- ID: M410

- Name: Dasatinib

- Relevance: HIGH

- As Found: Web-

- ID: M2889

- Name: Tyrosine Kinase Inhibitors

- Relevance: LOW

- As Found: Unknown

- ID: M324

- Name: Imatinib Mesylate

- Relevance: HIGH

- As Found: Voiding

- ID: M1346

- Name: Antineoplastic Agents, Immunological

- Relevance: LOW

- As Found: Unknown

- ID: M2342

- Name: Immune Checkpoint Inhibitors

- Relevance: LOW

- As Found: Unknown

- ID: M25820

- Name: Protein Kinase Inhibitors

- Relevance: LOW

- As Found: Unknown

- ID: M7951

- Name: Enzyme Inhibitors

- Relevance: LOW

- As Found: Unknown

- ID: T22

- Name: Tyrosine

- Relevance: LOW

- As Found: Unknown

### Intervention Browse Module - Meshes

- ID: C000582435

- Term: Pembrolizumab

- ID: D000068877

- Term: Imatinib Mesylate

- ID: D000069439

- Term: Dasatinib

- ID: C000498826

- Term: Nilotinib

### Misc Info Module

- Version Holder: 2024-05-24
